PMV Pharmaceuticals Funding: $92M Raised, Series C (2019)
PMV Pharmaceuticals is a Biotech company based in Princeton, New Jersey. It has raised $92M in total funding. Latest round: Series C.
PMV Pharmaceuticals funding overview
PMV Pharmaceuticals is a Biotech company based in Princeton, New Jersey. PMV Pharmaceuticals has raised $92M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in November 2019. The round record for PMV Pharmaceuticals runs through 2019; nothing later has been disclosed. Investors on record include OrbiMed, Osage University Partners, InterWest Partners, Nextech Invest, Viking Global Investors, Boxer Capital of Tavistock Group and 2 others. 8 distinct backers are named across the disclosed rounds.
PMV Pharmaceuticals at a glance
Total raised
$92M
Latest round
Series C
Latest round date
November 2019
Industry
Biotech
Headquarters
Princeton, New Jersey
Notable investors
OrbiMed, Osage University Partners, InterWest Partners, Nextech Invest, Viking Global Investors, Boxer Capital of Tavistock Group, Topspin, Euclidean Capital
Frequently asked about PMV Pharmaceuticals funding
How much has PMV Pharmaceuticals raised?
PMV Pharmaceuticals has raised $92M in total disclosed funding across the rounds on record.
Who has invested in PMV Pharmaceuticals?
OrbiMed, Osage University Partners, InterWest Partners, Nextech Invest, Viking Global Investors, Boxer Capital of Tavistock Group are named among the investors backing PMV Pharmaceuticals.
What was the latest PMV Pharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in November 2019.
Where is PMV Pharmaceuticals based?
PMV Pharmaceuticals is based in Princeton, New Jersey.
What sector does PMV Pharmaceuticals operate in?
PMV Pharmaceuticals is tracked under Biotech from Princeton, New Jersey, with $92M in disclosed funding.
When did PMV Pharmaceuticals last raise?
The last disclosed PMV Pharmaceuticals round closed in November 2019 at Series C.
Round data for PMV Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Princeton and backer lists below.
